ATE294188T1 - Peptidische inhibitoren der lfa-1/icam-1 interaktion - Google Patents

Peptidische inhibitoren der lfa-1/icam-1 interaktion

Info

Publication number
ATE294188T1
ATE294188T1 AT01942364T AT01942364T ATE294188T1 AT E294188 T1 ATE294188 T1 AT E294188T1 AT 01942364 T AT01942364 T AT 01942364T AT 01942364 T AT01942364 T AT 01942364T AT E294188 T1 ATE294188 T1 AT E294188T1
Authority
AT
Austria
Prior art keywords
icam
interaction
lfa
peptidic inhibitors
peptidic
Prior art date
Application number
AT01942364T
Other languages
English (en)
Inventor
Richard S Larson
Original Assignee
Richard S Larson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/483,550 external-priority patent/US6649592B1/en
Application filed by Richard S Larson filed Critical Richard S Larson
Application granted granted Critical
Publication of ATE294188T1 publication Critical patent/ATE294188T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT01942364T 2000-01-14 2001-01-16 Peptidische inhibitoren der lfa-1/icam-1 interaktion ATE294188T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/483,550 US6649592B1 (en) 2000-01-14 2000-01-14 Peptide inhibitors of LFA-1/ICAM-1 interaction
US09/760,599 US6630447B2 (en) 2000-01-14 2001-01-16 Peptide inhibitors of LFA-1/ICAM-1 interaction
PCT/US2001/001382 WO2001051508A1 (en) 2000-01-14 2001-01-16 Peptide inhibitors of lfa-1/icam-1 interaction

Publications (1)

Publication Number Publication Date
ATE294188T1 true ATE294188T1 (de) 2005-05-15

Family

ID=27047693

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01942364T ATE294188T1 (de) 2000-01-14 2001-01-16 Peptidische inhibitoren der lfa-1/icam-1 interaktion

Country Status (7)

Country Link
US (2) US6630447B2 (de)
EP (1) EP1263778B1 (de)
AT (1) ATE294188T1 (de)
AU (1) AU777721B2 (de)
CA (1) CA2397485A1 (de)
DE (1) DE60110396T2 (de)
WO (1) WO2001051508A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8680059B2 (en) 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US6844315B2 (en) 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
EP1138692A1 (de) 2000-03-29 2001-10-04 Erasmus Universiteit Rotterdam Fragmente des menschlichen Choriongonadotropins als Immunoregulatoren
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
USRE43279E1 (en) 2000-03-29 2012-03-27 Biotemp B.V. Compositions capable of reducing elevated blood urea concentration
US7358330B2 (en) 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
US7786084B2 (en) 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US7560433B2 (en) 2001-12-21 2009-07-14 Biotempt B.V. Treatment of multiple sclerosis (MS)
WO2004032861A2 (en) 2002-10-11 2004-04-22 Bristol-Myers Squibb Company Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents
US20050048579A1 (en) * 2003-07-07 2005-03-03 Larson Richard S. Tertiary structures of ICAM-1/LFA-1 modulators
US20050119186A1 (en) * 2003-07-22 2005-06-02 Larson Richard S. Potent peptide inhibitors and methods of use
CA2544678C (en) 2003-11-05 2013-12-31 Sunesis Pharmaceuticals, Inc. Modulators of cellular adhesion
TW200616634A (en) 2004-10-01 2006-06-01 Bristol Myers Squibb Co Crystalline forms and process for preparing spiro-hydantoin compounds
US7186727B2 (en) 2004-12-14 2007-03-06 Bristol-Myers Squibb Company Pyridyl-substituted spiro-hydantoin compounds and use thereof
DK2444079T3 (en) 2005-05-17 2017-01-30 Sarcode Bioscience Inc Compositions and Methods for the Treatment of Eye Diseases
JP4846799B2 (ja) 2005-07-05 2011-12-28 バイオテンプト ベー．フェー． 腫瘍の治療
EP1864692A1 (de) 2006-06-07 2007-12-12 Biotempt B.V. Verwendung von peptiden zum Schutz von Strahlenschäden
CN101443080B (zh) * 2006-03-07 2015-01-14 比奥滕普特公司 肽在控制辐射损伤中的用途
ES2830024T3 (es) 2007-10-19 2021-06-02 Novartis Ag Composiciones y métodos para el tratamiento del edema macular
WO2009128934A1 (en) 2008-04-15 2009-10-22 Sarcode Corporation Topical lfa-1 antagonists for use in localized treatment of immune related disorders
US8623322B2 (en) 2008-06-13 2014-01-07 Stc.Unm Non-invasive diagnostic agents and methods of diagnosing infectious disease
WO2020163876A1 (en) * 2019-02-08 2020-08-13 The Regents Of The University Of California Compositions and methods involving layilin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9613112D0 (en) * 1996-06-21 1996-08-28 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
US6630447B2 (en) 2003-10-07
AU2950201A (en) 2001-07-24
EP1263778A1 (de) 2002-12-11
WO2001051508A1 (en) 2001-07-19
AU777721B2 (en) 2004-10-28
US20050065070A1 (en) 2005-03-24
DE60110396D1 (de) 2005-06-02
DE60110396T2 (de) 2006-01-19
EP1263778B1 (de) 2005-04-27
US20010034326A1 (en) 2001-10-25
CA2397485A1 (en) 2001-07-19

Similar Documents

Publication Publication Date Title
ATE294188T1 (de) Peptidische inhibitoren der lfa-1/icam-1 interaktion
CY1109216T1 (el) Πεπτιδομιμητικοι αναστολεις πρωτεασης
ATE216879T1 (de) Verwendung von benzhydrylsulfinylderivaten zur behandlung der schläfigkeit medikamentösen ursprungs
DE60312309D1 (de) Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten
ATE206041T1 (de) Polyether-blockcopolymer micellare zusammensetzungen zur zielgerichteten verabreichung biologischer stoffe
ATE198050T1 (de) Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia
ATE347366T1 (de) Verwendung von activem vitamin d analoga zur behandlung von prostataerkrangkungen
DE59905954D1 (de) Dialkylfumarate zur behandlung von autoimmunerkrankungen
DE60315964D1 (de) Verbesserung der herstellung von endogenen gonadotropin
ATE290401T1 (de) Topisch anwendbare mittel gegen nagelpilzerkrankungen
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
CY1107087T1 (el) Μιμητικα θρομβοποιητινης
DE50306682D1 (de) Synergistische kombination von seidenproteinen
ATE385807T1 (de) Pharmazeutische verbindung und methoden zur behandlung von menschlichen karzinomen mittels arginin entzug
NO994330D0 (no) Metode for behandling av en tumor
DE60140960D1 (de) Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis
EA199700381A1 (ru) Диароматические соединения пропинила или диенила, промежуточные соединения, фармацевтические и косметические композиции на основе указанных соединений и применение косметических композиций
ATE489080T1 (de) Antitumorale mittel
ATE454155T1 (de) Verwendung von drospirenon zur behandlung von hypertension
ATE103804T1 (de) Pharmazeutische praeparate.
EE200200337A (et) Uued ühendid ning nende kasutamine
YU40796A (sh) Preparati i postupci za tretiranje obolenja koja izazivaju t ćelije
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
ATE504311T1 (de) Thrombin-derivierten peptiden zur förderung von herzgewebsreparatur

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties